The primary aim of this study was to reassess the predictive value of HLA-DQA1 and HLA-DRB1 haplotypes as a clinical screening tool for AZA-AP in IBD, considering also AZA-GI-INT and non-HLA factors. This evidence concerns the gene HLA-DRB1 and inflammatory bowel disease.